InflaRx (IFRX) Net Cash Flow (2016 - 2026)

InflaRx has disclosed Net Cash Flow across 11 years of filings, most recently posting -$1.6 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$1.6 million, down 104.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$34.8 million (down 244.42% YoY), and the FY2025 annual result was $1.4 million, down 67.91% from the prior year.
• Net Cash Flow came in at -$1.6 million for Q1 2026 at InflaRx, down from $11.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $32.2 million in Q1 2025 to a low of -$36.9 million in Q2 2025.
• The 5-year median for Net Cash Flow is -$1.2 million (2022), against an average of -$745579.3.
• Across the five-year window, Net Cash Flow soared 481.49% in 2022 and slumped 616.19% in 2023, its largest moves.
• InflaRx's Net Cash Flow stood at -$1.2 million in 2022, then plunged by 616.19% to -$8.8 million in 2023, then slipped by 12.95% to -$9.9 million in 2024, then surged by 213.69% to $11.3 million in 2025, then sank by 113.82% to -$1.6 million in 2026.
• The last three Net Cash Flow figures came in at -$1.6 million (Q1 2026), $11.3 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.